Jane Street Group, LLC Eagle Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 25,837 shares of EGRX stock, worth $15,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,837

Holding current value

$15,502

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.71 - $6.07 $95,855 - $156,830	25,837 New	25,837 $95,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $109,388 - $359,351	23,626 New	23,626 $123,000
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $304,844 - $547,654	-17,184 Reduced 26.49%	47,693 $927,000
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $1.09 Million - $1.48 Million	43,430 Added 202.5%	64,877 $1.84 Million
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $535,746 - $852,947	21,447 New	21,447 $626,000
Q2 2022 Aug 16, 2022	BUY	$41.26 - $51.35 $135,250 - $168,325	3,278 Added 35.09%	12,620 $561,000
Q1 2022 May 17, 2022	BUY	$44.58 - $52.6 $73,779 - $87,053	1,655 Added 21.53%	9,342 $462,000
Q4 2021 Feb 15, 2022	BUY	$45.82 - $56.9 $109,922 - $136,503	2,399 Added 45.37%	7,687 $391,000
Q3 2021 Nov 16, 2021	BUY	$43.79 - $55.78 $231,561 - $294,964	5,288 New	5,288 $295,000
Q1 2021 May 18, 2021	SELL	$40.32 - $50.97 $318,528 - $402,663	-7,900 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$41.72 - $51.34 $50,648 - $62,326	-1,214 Reduced 13.32%	7,900 $368,000
Q3 2020 Nov 17, 2020	BUY	$37.02 - $51.28 $337,400 - $467,365	9,114 New	9,114 $387,000
Q2 2018 Aug 15, 2018	SELL	$51.25 - $76.62 $206,076 - $308,089	-4,021 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $209,735 - $268,844	4,021 New	4,021 $212,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Eagle Pharmaceuticals, Inc. Transaction History